MedTrace Logo

Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis

NCT02924792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-12-08

No results posted yet for this study

Summary

In this study the impact of two CE marked and FDA approved sternal needles in comparison to intravenous access on the flow-rate of autologous reinfusion of whole blood and the possible hemolysis of red cells post-transfusion in a population of healthy military officers is investigated.

Conditions

  • Hypovolemic Shock
  • Hemorrhagic Shock

Interventions

DEVICE

Reinfusion - Sternal IO needle

DEVICE

Reinfusion - Intravenous needle

Sponsors & Collaborators

  • Ministry of Defence, Norway

    collaborator UNKNOWN

  • Haukeland University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-10-31
Completion
2017-12-05

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02924792 on ClinicalTrials.gov